{{Rsnum
|rsid=2069525
|Gene=CYP1A2
|Chromosome=15
|position=74748031
|Orientation=plus
|GMAF=0.06382
|Gene_s=CYP1A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 0.9 | 99.1
| HCB | 0.0 | 19.0 | 81.0
| JPT | 0.0 | 9.7 | 90.3
| YRI | 2.0 | 23.8 | 74.1
| ASW | 1.8 | 22.8 | 75.4
| CHB | 0.0 | 19.0 | 81.0
| CHD | 0.9 | 17.4 | 81.7
| GIH | 1.0 | 11.9 | 87.1
| LWK | 0.9 | 11.8 | 87.3
| MEX | 1.7 | 6.9 | 91.4
| MKK | 0.0 | 14.1 | 85.9
| TSI | 0.0 | 6.9 | 93.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=22141270
|Title=[Single nucleotide polymorphisms of CYP1A2 and their correlation with prostate cancer]
}}

{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}